SCHEMBL7347458

SCHEMBL7347458

Cn1ccnc1-c1ccc(NC(=O)OC(C)(C)C)c(F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.55
F2 P00734 1/20 0.46
F10 P00742 1/20 0.46
HDAC4 P56524 2/20 0.41
MAPK14 Q16539 1/20 0.40
SMO Q99835 1/20 0.40
EGLN2 Q96KS0 1/20 0.40
TLR9 Q9NR96 1/20 0.40
TLR8 Q9NR97 1/20 0.40
TLR7 Q9NYK1 1/20 0.40
FPR2 P25090 1/20 0.40
BRD9 Q9H8M2 1/20 0.39
RIPK2 O43353 1/20 0.39
GSK3B P49841 1/20 0.39
DYRK1A Q13627 1/20 0.39
KDR P35968 3/20 0.38
FLT1 P17948 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37
AAK1 Q2M2I8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24233456 0.89 AAK1 (0.46) CYP17A1F2F10HDAC4MAPK14
SCHEMBL8160635 0.76 CYP17A1 (0.49) CYP17A1F10EGLN2BRD9KDR
SCHEMBL2060873 0.76 BRD9 (0.44) BRD9
SCHEMBL31307614 0.76 CYP17A1 (0.56) CYP17A1HDAC4MAPK14SMOEGLN2
SCHEMBL15925258 0.76 CYP17A1 (0.54) CYP17A1BRD9KDRFLT1HTT
SCHEMBL24196483 0.75 CYP17A1 (0.58) CYP17A1EGLN2GSK3BDYRK1AABCB1
SCHEMBL8166208 0.75 CYP17A1 (0.55) CYP17A1EGLN2KDRABCB1
SCHEMBL24196257 0.74 CYP17A1 (0.57) CYP17A1KDRFLT1AAK1ABCB1
SCHEMBL29583356 0.74 CYP17A1 (0.59) CYP17A1EGLN2BRD9KDRAAK1
SCHEMBL857284 0.73 HTT (0.55) CYP17A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991638-A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-04-12 EP disclosed
WO-1998057951-A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-12-23 WO disclosed